Substantial evidence indicates a close relationship between eosinophils and basophils. We examined whether interleukin 5 (IL5), known to be eosinophilopoietic and capable of selectively regulating eosinophil functions, has an affect on basophil functions. IL5 enhanced basophil histamine release evoked by anti-IgE, formyl-methionyl-leucyl-phenylalanine, or ionophore A23187 at picomolar concentrations. Direct action of IL5 on human basophils was confirmed using highly purified basophil populations. These observations reveal the novel fact that IL5 is able to modulate basophil functions as well as eosinophil functions, and suggest that normal human basophils possess functional receptors for IL5.
Summary
Substantial evidence indicates a close relationship between eosinophils and basophils. We examined whether interleukin 5 (IL5), known to be eosinophilopoietic and capable of selectively regulating eosinophil functions, has an affect on basophil functions. IL5 enhanced basophil histamine release evoked by anti-IgE, formyl-methionyl-leucyl-phenylalanine, or ionophore A23187 at picomolar concentrations. Direct action of IL5 on human basophils was confirmed using highly purified basophil populations. These observations reveal the novel fact that IL5 is able to modulate basophil functions as well as eosinophil functions, and suggest that normal human basophils possess functional receptors for IL5.
I
L5 is a glycoprotein liberated from activated T cells, and has been shown to possess a variety of biological activities on different cell types (reviewed in reference 1) . Besides its action on T and B lymphocytes, IL5 acts on eosinophil lineages to induce their selective proliferation and differentiation in humans as well as in mice (2, 3) . Furthermore, IL5 stimulates mature eosinophils to enhance their functional activities, such as phagocytosis, motility, and the synthesis of biologically active molecules (4, 5) . In as much as substantial evidence strongly indicates a close relationship between basophils and eosinophils, and the fact that we observed that two eosinophilopoietic factors (granulocyte/macrophage [GM]-CSF and IL3) enhanced basophil histamine release (6), we address the question of whether IL5 does modulate basophil function . In this paper, we show that IL5 enhances histamine release from human basophils at picomolar concentrations.
Materials and Methods
Materials. Chemicals used in the experiments were purchased as previously described (6) . Purified human (h) (7) and mouse (8) rIIL5, produced by the Suntory Institute of Biomedical Research (Mishima, Osaka, Japan), was kindly donated by Dr. T Honjo, University of Kyoto (Kyoto, Japan) .
Histamine Release. Histamine release experiments were performed as described in the preceding report (6) . Briefly, leukocytes were separated from normal peripheral blood by dextran sedimentation, and were incubated in the presence of various concentrations of rIIr5 (400,ul) at 37°C. Incubation was carried out for 30 min, unless otherwise indicated, and histamine release was initiated by the addition of 100 itl of secretagogues . After additional incubation for 45 min at 37°C, supernatants were collected by centrifugation, and released histamine was measured by an automated fluorometric technique. Enhancement of histamine release by IIr5 was calculated by the following formula, as previously described (6) : percent enhancement = 100x (histamine released with a stimulus plus 11,5 -histamine released with a stimulus)/total histamine content . Each experiment was performed in duplicate or triplicate.
Purification ofBasophik In some experiments, purified basophils were used instead of crude leukocyte preparations. The details o£ the purification procedure will be described elsewhere (Yamaguchi, M ., K . Hirai, Y Morita, T Takaishi, K . Ohta, S . Suzuki, K. Motoyoshi, O. Kawanami, and K. Ito, manuscript submitted for publication) . In brief, basophils were separated from normal peripheral blood by discontinuous Pencoll (Pharmacia Fine Chemicals, Uppsala, Sweden) gradients with densities of 1 .070 and 1.079 g/ml, followed by negative panning selections using anti-Leu-5b (CD2), anti-Leu-12 (CD19), and anti-Leu-M3 (CD14) (Becton Dickinson & Co ., Mountain View, CA). Purified basophil suspensions were prepared with a purity of -90%. Neutrophils and lymphocytes were the most frequent contaminating cells, and preparations contained only small numbers of eosinophils (<0.5%) .
Results and Discussion
We first tested whether rhlL5 itself directly induced histamine release from basophils . However, we observed no significant release in the presence of 3 nM of rhIIL5 (n = 5) . We next studied the effect of rhIIr5 on histamine release evoked by various secretagogues . Pre-incubation of leukocytes with rhIIr5 resulted in the dose-dependent augmentation of histamine release initiated by anti-IgE, FMLP, or ionophore concentration of human IL-5 (pM) Figure 1 . Enhancement of histamine release by rhl1r5 upon stimulation with anti-IgE, FMLP, or ionophore A23187. leukocytes were preincubated for 30 min with serially diluted rhI1,5 and then stimulated with (" ) anti-IgE (1:3,000; n -7), (O) FMLP (10 -5 M; n = 5), or ( ") ionophore A23187 (0 .2 Ag/ml ; n = 5) . Control release in the absence of rhI1r5 was 39 .6 t 5 .6% (mean ± SEM) for anti-IgE, 38 .0 t 6 .9% for FMLP,, and 27 .8 ± 10 .7% for ionophore A23187. The bar represents SEM. A23187 (Fig . 1) . Maximal enhancement expressed as a percent increase against total histamine content was 19 .5 ± 3 .3% (mean ± SEM; range, 6 .4-32 .7%) for anti-IgE ;19 .5 ± 2 .8% (range, 12 .6-27.2%) for FMLP; and 19 .6 ± 0 .9% (range, 17.1-22 .3%) for ionophore A23187 . Irrespective of the stimuli used, the enhancement occurred at similar concentrations of rhILT5 ; half-maximal enhancement was observed at concentrations ranging from 10 to 30 pM, and the enhancement was observed in a dose-dependent fashion between 0.3 and 300 pM . Figure 2 . Enhancement of histamine release from purified basophils by rhllr5 . Basophils were purified from normal peripheral blood and tested as described above. (A) Anti-IgE (1:3,000 ; n = 5); (B) FMLP (10 -5 M ; n = 5) ; (C) ionophore A23187 (0.2 jig/ml ; n = 5) . Control release in the absence of rhIL5 was 27 .4 t 6 .2% (mean ± SEM) for anti-IgE, 40.0 t 4 .9% for FMLP, and 27 .2 ± 5 .2% for ionophore A23187 . The bar represents SEM .
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Since several lines of evidence have demonstrated that 11'5 activates mature eosinophils and certain eosinophil products such as major basic protein to induce histamine release from human basophils (9), we ex#mined whether rhII'5 directly acted on basophils rather than indirectly via contaminating eosinophils . We performed similar experiments using purified basophils instead of crude leukocyte preparations, and observed rhI1'5-induced dose-dependent augmentation comparable with that found using crude leukocyte preparations (Fig. 2) .
When rhI1r5 was removed by washing before stimulation, we still observed the enhancement, indicating that the presence of rhILr5 was not required for augmentation to occur during the release process (data not shown) . We reported in the preceding paper that the enhancement of histamine release by IL.3 or GM-CSF was time dependent and took place rapidly (6) . The enhancement by IL-5 was also a rapid process. Apparent enhancement was observed when the cells were pretreated with rhI1'5 for 1 min, and the augmentation reached maximum within 30 min of pre-treatment with rhILr5 (Fig. 3) .
Human IL'5 shares high sequence homology with murine IL5 (ti70%a at the amino acid level), and hence, murine IL-5 is active on human eosinophils (10) . A similar situation was found in basophils; murine 11'5 also enhanced human basophil histamine release (Fig. 4) .
Both eosinophils and basophils, constituting elements of circulating white blood cells, play crucial roles in hypersensitivity reactions. Both cells share several properties . First, some eosinophil-specific proteins, such as major basic protein and lysophospholipase (Charcot-Leiden crystal), also exist in basophils (11, 12) . Second, both cells generate LTC4 as a major product of aracbidonic acid metabolism . Third, in clonal analyses, the coexistence of eosinophils and basophils has been observed in single colonies derived from human hemopoietic precursors (13, 14) . Finally, hybrid cells, which possess both eosinophilic and basophilic granules, have been found in semisolid cultures (14) as well as in the peripheral blood of patients with chronic myelogenous leukemia (15) . These observations collectively indicate the close relationship between Received for publication 26 July 1990.
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Hirai et al. Brief Definitive Report release was amplified by 11,3 and GM-CSF, while G-CSF, M-CSF, and 114 had no effect at all (6) . In the present paper, we demonstrate that 11,5 also enhances basophil histamine release. It is of interest that all three eosinophilopoietic factors also stimulate basophils to enhance histamine release, and these observations provide additional evidence to support the notion that basophils and eosinophils closely resemble each other; the same hemopoietic growth factors regulate biological functions of both eosinophils and basophils . The fact that IL5 modulates basophil functions in vitro indicates a possible mechanism of in vivo regulation by IL5 in terms of clinical manifestations of hypersensitivity reactions. Migrated basophils at the sites of inflammation are believed to contribute to IgE-mediated late-phase reactions. In concert with IIr3 and GM-CSF, and possibly with IL8, known to stimulate basophils to trigger histamine release (16) and to induce chemoaatis (17) , IL5 modulates basophil histamine release and could participate in exacerbation and prolongation of hypersensitivity reactions . In fact, HA as well as IL3 and GM-CSF, induced migration of purified basophils (M. Yamaguchi et al., unpublished observation) .
In conclusion, the observation that IL5 is active on basophils at picomolar concentrations is a novel finding and suggests the presence of functional receptors for 111,5 on normal basophils . These findings add new insight into mechanisms controlling hypersensitivity reactions as well as human basophilopoiesis .
